Audentes Therapeutics, Inc.
SEC CIK 1628738 · BOLD · last insider filing 2020-01-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lange Louis G | Director | filed 2016 - 2020 |
| Patterson Matthew R | Director · President & CEO | filed 2016 - 2020 |
| Goldberg Mark Alan | Director | filed 2017 - 2020 |
| Smith Julie | Director | filed 2016 - 2020 |
| Schuetz Thomas J. | Director | filed 2016 - 2020 |
| Morrison Scott W | Director | filed 2016 - 2020 |
| Jarrett Jennifer | Director | filed 2017 - 2020 |
| Parmar Kush | Director | filed 2016 - 2018 |
| Orbimed Advisors LLC | Director | filed 2016 - 2018 |
| Orbimed Capital GP IV LLC | Director | filed 2016 - 2018 |
| Squinto Stephen P | Director | filed 2016 - 2017 |
| Isaly Samuel D | Director | filed 2016 - 2017 |
| Silverstein Jonathan | Director | filed 2016 - 2016 |
| Woiwode Thomas | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Soloway Thomas P | Senior Vice President, CFO | filed 2016 - 2020 |
| Holles Natalie C. | Senior Vice President, COO | filed 2016 - 2020 |
| Conner Edward R. | SVP, Chief Medical Officer | filed 2019 - 2020 |
| Mosbrooker Eric | SVP, Chief Commercial Officer | filed 2019 - 2020 |
| Meltz Mark A | SVP, General Counsel | filed 2019 - 2020 |
| Prasad Suyash | Senior VP & Chief Med Officer | filed 2016 - 2019 |
| Newman Mary | SVP, Regulatory Affairs | filed 2016 - 2018 |
| Gray John T. | Senior Vice President, R & D | filed 2016 - 2018 |
| Nagler David | SVP, HR & Corp. Affairs | filed 2016 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.